Progress in understanding RAS-driven cancers relies on collaboration across disciplines, institutions and geographic boundaries. Molecular biologists, clinicians, computational scientists and translational researchers each contribute unique perspectives to a complex problem.
The European RAS Initiative aims to support knowledge exchange, encourage interdisciplinary discussion and strengthen connections within the cancer research community, with RAS signaling as a shared focal point.